These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20199224)

  • 1. Radiosensitization of murine normoblasts in vivo by bromodeoxyuridine to the genotoxicity and cytotoxicity of the bone-seeking radiopharmaceutical 153Sm-EDTMP.
    Morales-Avila E; Ferro-Flores G; Vallarino-Kelly T; Morales-Ramírez P
    Radiat Res; 2010 Mar; 173(3):386-91. PubMed ID: 20199224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic and genotoxic effect of the [166Dy]Dy/166Ho-EDTMP in vivo generator system in mice.
    Pedraza-López M; Ferro-Flores G; Arteaga de Murphy C; Morales-Ramírez P; Piedras-Ross J; Murphy-Stack E; Hernández-Oviedo O
    Nucl Med Biol; 2004 Nov; 31(8):1079-85. PubMed ID: 15607490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotoxicity kinetics in murine normoblasts as an approach for the in vivo action of difluorodeoxycytidine.
    Morales-Ramírez P; Vallarino-Kelly T; Cruz-Vallejo V
    Cancer Chemother Pharmacol; 2017 May; 79(5):843-853. PubMed ID: 28324147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of micronucleus induction and cytotoxic activity of colchicine in murine erythroblast in vivo.
    Vallarino-Kelly T; Morales-Ramírez P
    Mutat Res; 2001 Aug; 495(1-2):51-9. PubMed ID: 11448642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose treatment with (186)Re-HEDP or (153)Sm-EDTMP combined with amifostine in a rabbit model.
    Brenner W; Kampen WU; von Forstner C; Brümmer C; Zuhayra M; Muhle C; Czech N; Henze E
    J Nucl Med; 2001 Oct; 42(10):1545-50. PubMed ID: 11585871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiopharmaceutical therapy of 5T33 murine myeloma by sequential treatment with samarium-153 ethylenediaminetetramethylene phosphonate, melphalan, and bone marrow transplantation.
    Turner JH; Claringbold PG; Manning LS; O'Donoghue HL; Berger JD; Glancy RJ
    J Natl Cancer Inst; 1993 Sep; 85(18):1508-13. PubMed ID: 8360933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 153Sm-ethylenediaminetetramethylene phosphonate on physeal and articular cartilage in juvenile rabbits.
    Essman SC; Lattimer J; Cook JL; Turnquist S; Kuroki K
    J Nucl Med; 2003 Sep; 44(9):1510-5. PubMed ID: 12960200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of increasing doses of samarium-153-ethylenediaminetetramethylene phosphonate on axial and appendicular skeletal growth in juvenile rabbits.
    Essman SC; Lewis MR; Fox DB
    Nucl Med Biol; 2008 Feb; 35(2):219-25. PubMed ID: 18312832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Samarium lexidronam (153Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma.
    Anderson P; Nuñez R
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1517-27. PubMed ID: 18020921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the [(153)Sm]Sm-EDTMP pharmacokinetics and estimation of radiation absorbed dose on an individual basis.
    Vigna L; Matheoud R; Ridone S; Arginelli D; Della Monica P; Rudoni M; Inglese E; Brambilla M
    Phys Med; 2011 Jul; 27(3):144-52. PubMed ID: 20864370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of samarium-153 and holmium-166-EDTMP in the normal baboon model.
    Louw WK; Dormehl IC; van Rensburg AJ; Hugo N; Alberts AS; Forsyth OE; Beverley G; Sweetlove MA; Marais J; Lötter MG; van Aswegen A
    Nucl Med Biol; 1996 Nov; 23(8):935-40. PubMed ID: 9004281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated human absorbed dose of a new (153)Sm bone seeking agent based on biodistribution data in mice: Comparison with (153)Sm-EDTMP.
    Yousefnia H; Zolghadri S
    Phys Med; 2015 Nov; 31(7):714-9. PubMed ID: 26095757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation safety considerations for the bone seeking radiopharmaceuticals. 89SrCl2, 186Re-HEDP and 153Sm-EDTMP.
    Lam MG; Hoekstra A; de Klerk JM; van Rijk PP; Zonnenberg BA
    Nuklearmedizin; 2009; 48(1):37-43. PubMed ID: 19212610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemcitabine radiosensitization after high-dose samarium for osteoblastic osteosarcoma.
    Anderson PM; Wiseman GA; Erlandson L; Rodriguez V; Trotz B; Dubansky SA; Albritton K
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6895-900. PubMed ID: 16203780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of ethylenediamine tetramethylene phosphonic acid in normal bone after multiple applications. A non-human primate study.
    Dormehl IC; Louw WK; Schneeweiss FH; Milner R; Schmitt G; Carl U; Croft SA
    Arzneimittelforschung; 1998 Apr; 48(4):408-14. PubMed ID: 9608885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone uptake studies in rabbits before and after high-dose treatment with 153Sm-EDTMP or 186Re-HEDP.
    Brenner W; Kampen WU; Brümmer C; von Forstner C; Zuhayra M; Czech N; Muhle C; Henze E
    J Nucl Med; 2003 Feb; 44(2):247-51. PubMed ID: 12571217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multispecies animal investigation on biodistribution, pharmacokinetics and toxicity of 177Lu-EDTMP, a potential bone pain palliation agent.
    Máthé D; Balogh L; Polyák A; Király R; Márián T; Pawlak D; Zaknun JJ; Pillai MR; Jánoki GA
    Nucl Med Biol; 2010 Feb; 37(2):215-26. PubMed ID: 20152721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo Characterization of the Radiosensitizing Effect of a Very Low Dose of BrdU in Murine Cells Exposed to Low-Dose Radiation.
    Cruz-Vallejo V; Ortíz-Muñiz R; Vallarino-Kelly T; Cervantes-Ríos E; Morales-Ramírez P
    Environ Mol Mutagen; 2019 Jul; 60(6):534-545. PubMed ID: 30851126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraorgan biodistribution and dosimetry of 153Sm-ethylenediaminetetramethylene phosphonate in juvenile rabbit tibia: implications for targeted radiotherapy of osteosarcoma.
    Essman SC; Lewis MR; Miller WH
    J Nucl Med; 2005 Dec; 46(12):2076-82. PubMed ID: 16330573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preclinical investigation of the saturation and dosimetry of 153Sm-DOTMP as a bone-seeking radiopharmaceutical.
    Simón J; Frank RK; Crump DK; Erwin WD; Ueno NT; Wendt RE
    Nucl Med Biol; 2012 Aug; 39(6):770-6. PubMed ID: 22459336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.